Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Mapping the incidentalome: estimating incidental findings generated through clinical pharmacogenomics testing.

Genetics in medicine : official journal of the American College of Medical Genetics - 1 May 2013

Westbrook Matthew J, Wright M Frances, Van Driest Sara L, McGregor Tracy L, Denny Joshua C, Zuvich Rebecca L, Clayton Ellen Wright, Brothers Kyle B

Abstract excerpt

PURPOSE: Greater clinical validity and economic feasibility are driving the more widespread use of multiplex genetic technologies in routine clinical care, especially for applications in pharmacogenomics. Empirical data on the numbers and types of incidental findings generated through such testing are needed to develop policies and practices related to their clinical use. Of particular importance are disparities...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Genetic Association Studies
Share to Genetic Predisposition to Disease

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Testing

Share to Genomics

Share to Incidental Findings

Share to Odds Ratio

Share to Pharmacogenetics

Share to Population Groups

Source

Open in PubMed Open full text

Identifiers

PMID: 23196672
DOI: 10.1038/gim.2012.147
PMCID: PMC3648626

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Mapping the incidentalome: estimating incidental findings generated through clinical pharmacogenomics testing.PMID 23196672Read ↗

Implications of the incidentalome for clinical pharmacogenomics.Semantic proximity Read ↗

Pharmacogenomic incidental findings in 308 families: The NIH Undiagnosed Diseases Program experience.Semantic proximity Read ↗

Genome Sequencing Enhances Precision and Clinical Utility of Pharmacogenetic Data Compared to Arrays.Semantic proximity Read ↗

Incidental variants are critical for genomics.Semantic proximity Read ↗

Genomic research and incidental findings.Semantic proximity Read ↗

Frequency and management of medically actionable incidental findings from genome and exome sequencing data: a systematic review.Semantic proximity Read ↗

Pharmacogenomics in the era of next generation sequencing – from byte to bedsideSemantic proximity Read ↗

Managing incidental findings in exome sequencing for research.Semantic proximity Read ↗

Requirements for comprehensive pharmacogenetic genotyping platforms.Semantic proximity Read ↗

Recommendations for returning genomic incidental findings? We need to talk!Semantic proximity Read ↗

Opportunistic screening for broad range of medically relevant secondary findings: Laboratory benefits and burdens.Semantic proximity Read ↗

CLIA-tested genetic variants on commercial SNP arrays: potential for incidental findings in genome-wide association studies.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.